23
Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS http://www.research.chop.edu/programs/johnsonlab/features/hiv_type_1.php

Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

  • View
    213

  • Download
    2

Embed Size (px)

Citation preview

Page 1: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

Dr. Abdulkarim Alhethail

Assistant Professor

HIV & AIDS

http://www.research.chop.edu/programs/johnsonlab/features/hiv_type_1.php

Page 2: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

Outline• Introduction to HIV & AIDS

• HIV main structural components & life cycle

• HIV pathogenesis

• Stages of HIV infection

• Persistent generalized lymphadenopathy (PGL)

• AIDS related complex (ARC)

• Transmission

• Diagnosis

• Serological profile

• Management & treatment

Page 3: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

• Is a retrovirus that causes human AIDS, and was initially identified in 1983.

Human immunodeficiency virus (HIV)

Acquired immunodeficiency syndrome (AIDS)

• Is the end stage of the disease that is associated with opportunistic infections and unusual cancer (Kaposi sarcoma).

Page 4: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

Characteristics of HIV

• Family of Retroviridae.

Virion consist of:

• Glycoprotein envelope (gp120, gp41).

• Matrix layer.

• Capsid.

• Two copies of ssRNA.

• Enzymes (reverse transcriptase, integrase, protease).

Page 5: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

HIV genome

The genome encodes 9 proteins:

• 3 structural proteins (Core, enzymes, envelope)

• 6 non-structural proteins (Tat, Nef, Rev, Vif, Vpr, Vpu)

Page 6: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

HIV life cycle

Page 7: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

There are two HIV species known to cause AIDS in human HIV-1 and HIV-2, and the overall sequence homology between HIV-1 & HIV-2 is less than 50%.

HIV species

Page 8: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

• HIV-1:– Causes HIV infection worldwide.– Highly virulent. – Highly susceptible to mutations.

• HIV-2: – Causes the infection in specific regions e.g. West Africa – Relatively less virulent. – Relatively less susceptible to mutations.

Continued..

Page 9: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

HIV pathogenesis

Page 10: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

Stages of HIV infection

The course of HIV infection goes through 3 stages: Acute phase, Chronic phase, and AIDS.

Page 11: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

Acute phase:

• Lasts for about 12 weeks.

• Rapid viral replication (high viral load).

• Gradual decrease in CD4 cell count.

• 50-70% of patients develop symptoms resemble infectious mononucleosis or Flu (fever, headache, anorexia, fatigue, lymphadenopathy, & skin rash).

• 20% of patients may develop aseptic meningitis.

Page 12: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

Chronic phase:

• Lasts for about 10 yrs in adults.

• Low viral load.

• CD4 count > 500/ml

• Totally asymptomatic but the patients still contagious.

Page 13: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

AIDS:

• The end stage of the disease.

• Continuous viral replication (high viral load).

• Marked decrease in CD4 cell count < 200

• Persistent or frequent multiple opportunistic infections, and unusual cancers (Kaposi sarcoma).

Page 14: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

Persistent generalized lymphadenopathy (PGL)

Is defined as enlargement of lymph nodes for at least 1 cm in diameter, and must meet the following conditions:

• In two or more extra inguinal area.

• Persists for at least 3 months.

• In the absence of any illness or medication known to cause PGL.

Page 15: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

AIDS-related complex (ARC)

Is the clinical symptoms that come before AIDS and may include the following:

• Fever of unknown origin that persists > 1 month.

• Chronic diarrhea, persisting > 1 month.

• Weight loss > 10% of the original weight.

• Fatigue.

Page 16: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

Transmission of HIV

• Sexually (unprotected sex).

• Direct exposure to infected blood (receiving blood from infected donor).

• Using contaminated or not adequately sterilized tools in surgical or cosmetic practice (dental, tattooing, body piercing).

• Sharing contaminated needles, razors, or tooth brushes.

• Perinatally (from mother to baby).

Page 17: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

Diagnosis

• Patient history with or without clinical symptoms.

• Detection of both HIV Ag & Ab in the patient serum.

• If repeatedly reactive (positive), do confirmatory tests (Western Blot, RIBA, PCR).

• Blood viral load by PCR is also used to follow up a patient treatment.

Page 18: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

Serological profile of HIV infection

Page 19: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

Management

No vaccine available to prevent HIV infection, and thus education is the best strategy to use to manage HIV spread as follow:

• Religious education (by teaching the risk of making prohibited relations).

• Health education (by teaching the risk of using shared materials).

• Advise of using condoms when necessary.

Page 20: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

Treatment

• Is a combined therapy known as high active antiretroviral therapy (HAART).

• NOTE: HAART does not clear the virus, and should be taken all life.

• NOTE: HAART treated patients are still contagious even if their blood viral load below detection (< 50 copies/μL).

• HAART is usually composed of two reverse transcriptase inhibitors and one protease inhibitor.

Page 21: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

• There are two types of reverse transcriptase inhibitors:• Nucleoside analog RT inhibitors for HIV-1 & HIV-2: - Zidovudine (AZT) - Zalcitabine (DDC)

- Stavudine (D4T) - Lamivudine (3TC)

• Non-nucleoside analog RT inhibitors for HIV-1 only:- Nevirapine - Delavirdine - Efavirenz

• Proteases inhibitors include:

-Saquinavir - Indinavir

-Nelfinavir - Ritonavir

Continued..

Page 22: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

Goals of HIV treatment

• To inhibit viral replication.

• To control chronic immune activation and keep the immune system close to the normal state.

• To prevent the development of opportunistic infection.

• To minimize the chance of viral transmission especially from mother to neonate.

Page 23: Dr. Abdulkarim Alhethail Assistant Professor HIV & AIDS

Thank you for your attention ! Thank you for your attention !